This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Magellan (MGLN) Unit Launches Solution to Improve Behavioral Care
by Zacks Equity Research
Magellan's (MGLN) unit - Magellan Healthcare - together with NeuroFlow, introduces a collaborative care management solution in a bid to ease the behavioral health treatment process.
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $387.01, marking a -1.38% move from the previous day.
Why Should You Hold Molina Healthcare (MOH) in Your Portfolio?
by Zacks Equity Research
Riding high on strategic measures and membership growth, Molina Healthcare (MOH) holds enough potential to reap benefits for investors.
Cigna's (CI) 2022 Expansion Plans to Boost MA Customer Base
by Zacks Equity Research
Cigna (CI) unveils enhanced health plans for its customers to opt for in the 2022 Medicare AEP period. The company will foray into newer counties and states to offer enhanced health outcomes.
UnitedHealth (UNH) Woos MA Members With Updated 2022 Plans
by Zacks Equity Research
UnitedHealth (UNH) announces MA plans for 2022 to maintain its leadership position in the market.
Here's Why You Should Retain Cigna (CI) Stock for Now
by Zacks Equity Research
Cigna (CI) is benefiting on the back of robust segmental performances and well-diversified healthcare suite. A strong partner network throughout U.S. is an added advantage.
Down 7.8% in 4 Weeks, Here's Why UnitedHealth (UNH) Looks Ripe for a Turnaround
by Zacks Equity Research
UnitedHealth (UNH) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
The Zacks Analyst Blog Highlights: Salesforce, JPMorgan, Walmart, UnitedHealth and Microsoft
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Salesforce, JPMorgan, Walmart, UnitedHealth and Microsoft
UnitedHealth (UNH) Unit to Offer Better Pharmacy Care in Arizona
by Zacks Equity Research
Genoa, which comes under UnitedHealth Group's (UNH) subsidiary Optum, opens a pharmacy in one of Arizona's clinics for offering enhanced pharmacy care for behavioral health patients.
5 Buy-Ranked Blue-Chip Stocks to Gain in a Capricious Market
by Nalak Das
We have narrowed down our search to five Dow stocks that have strong growth potential for the rest of 2021. These are: CRM, MSFT, WMT, UNH and JPM.
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $405.27, moving -0.44% from the previous trading session.
Humana (HUM), Kelsey-Seybold Clinic Tie Up for Better Healthcare
by Zacks Equity Research
Humana (HUM) inks a deal with Kelsey-Seybold Clinic in Houston to offer its Humana Medicare Advantage HMO members enriched healthcare facilities.
3 HMO Stocks That Outperformed the S&P Index in a Year's Time
by Srijita Guha
Membership growth, mergers and buyouts, and investment in technology are likely to aid health insurance companies like ANTM, MOH, and UNH to outperform the S&P Index.
Here is Why UnitedHealth (UNH) Should Grace Your Portfolio
by Zacks Equity Research
A solid positioning in an ever-growing industry makes UnitedHealth (UNH) a top pick for strong investment gains.
Has UnitedHealth Group (UNH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (UNH) Outperforming Other Medical Stocks This Year?
Zacks Industry Outlook Highlights: UnitedHealth Group, Anthem, Humana and Centene Corp
by Zacks Equity Research
Zacks Industry Outlook Highlights: UnitedHealth Group, Anthem, Humana and Centene Corp
4 HMO Stocks in Focus as Government Backs Healthcare Reform
by Sapna Bagaria
The Health insurance industry is poised to grow on the back of a better regulatory environment. Aging demography, automation plus mergers and acquisitions are other catalysts.
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $412.70, moving -1.78% from the previous trading session.
The Zacks Analyst Blog Highlights: Alphabet, UnitedHealth, Medtronic, Starbucks and Caterpillar
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alphabet, UnitedHealth, Medtronic, Starbucks and Caterpillar
Top Stock Reports for Alphabet, UnitedHealth & Medtronic
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), UnitedHealth Group Incorporated (UNH), and Medtronic plc (MDT).
UnitedHealth Group (UNH) Stock Moves -0.48%: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $412.54, moving -0.48% from the previous trading session.
Humana (HUM), Curant Health Team Up to Aid Chronic Patients
by Zacks Equity Research
Humana (HUM) inks a deal with Curant Health to offer its members with chronic diseases enriched healthcare facilities.
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $415.39, marking a -1.39% move from the previous day.
New to Investing? This 1 Medical Stock Could Be the Perfect Starting Point
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Here's Why You Should Hold Molina Healthcare (MOH) Stock Now
by Zacks Equity Research
Riding high on its rising membership, a healthy revenue stream and restructuring measures, Molina Healthcare (MOH) holds potential to reap benefits for investors.